trending Market Intelligence /marketintelligence/en/news-insights/trending/h-kwzmcrsmh4oleycz1lsa2 content
BY CONTINUING TO USE THIS SITE, YOU ARE AGREEING TO OUR USE OF COOKIES. REVIEW OUR
PRIVACY & COOKIE NOTICE
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *

* Required

In this list

Aurinia closes $28.8M bought-deal offering

State Of Singapore Online Video Subscription

Power Forecast Briefing: Capacity Shortfalls to Test the Renewable Energy Transition

Episode 43 - More Change, M&A On Horizon For Equity Research Industry

Cable Nets Struggle With Little Revenue Growth Expanding Programming Budgets


Aurinia closes $28.8M bought-deal offering

Aurinia Pharmaceuticals Inc. closed its $28.8 million bought-deal offering, which included $3.8 million pursuant to an exercise of the underwriter's overallotment option, for the sale of 12,777,775 units at $2.25 per unit.

Each unit consists of one common share and one-half of one common share purchase warrant. Each warrant will be exercisable into one share for $3 apiece for a period of 5 years after the offering closes.

H.C. Wainwright & Co. LLC was sole book-running manager and Cormark Securities Inc. was co-manager for the offering.